// App-Quantinova.ai

3021 : Development of small molecule direct AMPK activators for the treatment of cancer

Researchers

Presenter

  • Yasumichi Hitoshi

Principal Investigators

  • Yonchu Jenkins

  • Yingwu Li

  • Elmer Sampang

  • Xiang Xu

  • Guodong Dong

  • Jianing Huang

  • Nan Lin

  • Dane Goff

  • Simon Shaw

  • Luke Boralsky

  • Rajinder Singh

  • Sarkiz D. Issakani

  • Donald G. Payan

Medical Centers

  • Threshold Pharmaceuticals, Inc., South San Francisco, CA

Locations

  • United States

Companies

  • Rigel Pharmaceutical

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Liver cancer

  • Solid malignancies

Biomarkers

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • Liver kinase B1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved